# Arbutus Biopharma Corp: Form 20-F for the period ended Dec 31, 2012

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 20-F
- Filed: 2013-03-27
- Accepted by EDGAR: Mar 27, 2013, 16:59 ET
- Period: 2012-12-31
- Accession: 0001193125-13-129590
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000119312513129590/d508557d20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000119312513129590/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2012-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Diluted shares (weighted) | 12 months, 2012-01-01 to 2012-12-31 | 14,320,814 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Shares outstanding | at 2012-12-31 | 14,305,356 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000119312513129590/d508557d20f.htm

Filed Mar 27, 2013.
Source: SEC EDGAR, the filing index for accession 0001193125-13-129590. Last ingested by Listed: Nov 12, 2026, 17:55 ET. No prices; not investment advice.
